Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

SELL
$209.01 - $232.56 $710,634 - $790,704
-3,400 Reduced 10.86%
27,900 $6.1 Million
Q4 2023

Feb 15, 2024

SELL
$197.69 - $227.29 $593,070 - $681,870
-3,000 Reduced 8.75%
31,300 $7.11 Million
Q3 2023

Nov 09, 2023

BUY
$201.05 - $221.7 $603,150 - $665,100
3,000 Added 9.58%
34,300 $6.9 Million
Q2 2023

Aug 09, 2023

SELL
$211.93 - $241.33 $1.25 Million - $1.42 Million
-5,900 Reduced 15.86%
31,300 $7.55 Million
Q1 2023

May 12, 2023

SELL
$213.32 - $257.83 $405,308 - $489,876
-1,900 Reduced 4.86%
37,200 $8.53 Million
Q4 2022

Feb 13, 2023

SELL
$203.72 - $248.97 $244,464 - $298,764
-1,200 Reduced 2.98%
39,100 $9.21 Million
Q3 2022

Nov 14, 2022

BUY
$204.81 - $262.19 $634,911 - $812,789
3,100 Added 8.33%
40,300 $8.25 Million
Q2 2022

Aug 15, 2022

SELL
$213.86 - $277.87 $2.69 Million - $3.5 Million
-12,600 Reduced 25.3%
37,200 $8.72 Million
Q4 2021

Feb 15, 2022

SELL
$271.6 - $314.21 $244,440 - $282,789
-900 Reduced 1.78%
49,800 $15.6 Million
Q3 2021

Nov 12, 2021

SELL
$274.82 - $308.34 $219,856 - $246,671
-800 Reduced 1.55%
50,700 $14.3 Million
Q2 2021

Aug 16, 2021

BUY
$251.87 - $278.14 $2.01 Million - $2.23 Million
8,000 Added 18.39%
51,500 $14.2 Million
Q1 2021

May 17, 2021

BUY
$204.88 - $255.03 $819,520 - $1.02 Million
4,000 Added 10.13%
43,500 $11.1 Million
Q4 2020

Feb 12, 2021

BUY
$186.91 - $214.42 $149,528 - $171,536
800 Added 2.07%
39,500 $8.04 Million
Q3 2020

Nov 12, 2020

BUY
$167.03 - $201.3 $133,624 - $161,040
800 Added 2.11%
38,700 $7.29 Million
Q2 2020

Aug 06, 2020

SELL
$113.31 - $182.44 $487,233 - $784,492
-4,300 Reduced 10.19%
37,900 $6.3 Million
Q1 2020

May 13, 2020

SELL
$104.32 - $195.28 $20,864 - $39,056
-200 Reduced 0.47%
42,200 $5.33 Million
Q4 2019

Feb 10, 2020

BUY
$163.48 - $173.61 $294,264 - $312,498
1,800 Added 4.43%
42,400 $7.17 Million
Q3 2019

Nov 19, 2019

SELL
$159.77 - $178.1 $734,942 - $819,260
-4,600 Reduced 10.18%
40,600 $6.82 Million
Q2 2019

Aug 15, 2019

SELL
$144.16 - $172.9 $677,552 - $812,630
-4,700 Reduced 9.42%
45,200 $7.82 Million
Q1 2019

May 14, 2019

BUY
$123.7 - $156.3 $470,060 - $593,940
3,800 Added 8.24%
49,900 $7.63 Million
Q3 2018

Oct 16, 2018

BUY
$167.67 - $188.27 $687,447 - $771,907
4,100 Added 9.76%
46,100 $8.01 Million
Q2 2018

Aug 17, 2018

SELL
$160.33 - $189.41 $1.7 Million - $2.01 Million
-10,600 Reduced 20.15%
42,000 $7.54 Million
Q1 2018

Apr 10, 2018

SELL
$161.53 - $178.11 $5.19 Million - $5.72 Million
-32,141 Reduced 37.93%
52,600 $8.51 Million
Q4 2017

Feb 14, 2018

SELL
$147.99 - $163.95 $334,309 - $370,363
-2,259 Reduced 2.6%
84,741 $13.5 Million
Q3 2017

Oct 31, 2017

BUY
$149.47 - $160.56 $13 Million - $14 Million
87,000
87,000 $13.1 Million

Others Institutions Holding LH

About LABORATORY CORP OF AMERICA HOLDINGS


  • Ticker LH
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 89,600,000
  • Market Cap $20.8B
  • Description
  • Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...
More about LH
Track This Portfolio

Track Andra Ap Fonden Portfolio

Follow Andra Ap Fonden and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Andra Ap Fonden, based on Form 13F filings with the SEC.

News

Stay updated on Andra Ap Fonden with notifications on news.